Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
International Journal of Molecular Sciences|June 19, 2024
Targeted Treatment against Cancer Stem Cells in Colorectal CancerJulia Martínez-Pérez, Carlos Torrado, María A Domínguez-Cejudo, et al.
International Journal of Molecular Sciences|June 18, 2015
Colorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology ApproachMoisés Blanco-Calvo, Ángel Concha, Angélica Figueroa, et al.
BMC Cancer|November 5, 2011
Hakai reduces cell-substratum adhesion and increases epithelial cell invasionTeresa Rodríguez-Rigueiro, Manuel Valladares-Ayerbes, Mar Haz-Conde, et al.
International Journal of Molecular Sciences|July 28, 2012
State of the art in silico tools for the study of signaling pathways in cancerVanessa Medina Villaamil, Guadalupe Aparicio Gallego, Isabel Santamarina Cainzos, et al.
Sensors (Basel, Switzerland)|September 27, 2012
Circulating microRNAs: molecular microsensors in gastrointestinal cancerMoisés Blanco-Calvo, Lourdes Calvo, Angélica Figueroa, et al.
ESMO Open|March 14, 2018
Exploratory pooled analysis evaluating the effect of sequence of biological therapies on overall survival in patients with RAS wild-type metastatic colorectal carcinomaMarc Peeters, Frédéric Forget, Meinolf Karthaus, et al.
Cancer Chemotherapy and Pharmacology|December 17, 2009
Anemia response and safety to epoetin-beta treatment in patients with neoadjuvant therapy prior to primary digestive tract tumor surgeryAntonio Gómez, Mercedes Salgado, Manuel Valladares-Ayerbes, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 16, 2010
Efficacy of epoetin-beta 30,000 IU/week in correcting anaemia in patients with gastrointestinal tumours subjected to concomitant chemoradiotherapyAntonio Gómez, Mercedes Salgado, Manuel Valladares-Ayerbes, et al.
Expert Opinion on Biological Therapy|March 11, 2025
State of the art of the molecular hyperselection to guide treatment with anti-EGFR antibodies in RAS WT mCRC: implications for clinical practice and future perspectivesPilar García-Alfonso, Manuel Valladares-Ayerbes, Andrés J Muñoz Martín, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 19, 2008
Origin of renal cell carcinomasManuel Valladares Ayerbes, Guadalupe Aparicio Gallego, Silvia Díaz Prado, et al.
Pageof 6